Postoperative pulmonary complications (PPCs) are common, costly, and increase patient
mortality. Changes to the respiratory system occur immediately on induction of general …

We reviewed systematically sugammadex vs neostigmine for reversing neuromuscular
blockade. We included 17 randomised controlled trials with 1553 participants. Sugammadex …

Objectives To provide an update to the 1999 French guidelines on “Muscle relaxants and
reversal in anaesthesia”, a consensus committee of sixteen experts was convened. A formal …

Background: Postoperative residual neuromuscular blockade related to non-depolarizing
neuromuscular blocking agents may be associated with pulmonary complications. In this …

Background: Elderly patients are at increased risk for anesthesia-related complications.
Postoperative residual neuromuscular block (PRNB) in the elderly, defined as a train-of-four …

The use of anticholinesterases to reverse residual neuromuscular block at the end of
surgery became routine practice in the 1950s. These drugs could only be used when …

Abstract Purpose of Review The purpose of this review is to assess how residual
neuromuscular block impacts postoperative pulmonary complications and whether we can …

Background Residual neuromuscular block is associated with an increased risk of
postoperative pulmonary complications in retrospective studies. The aim of our study was to …

Introduction: Sugammadex is a modified cyclodextrin that is able to reverse neuromuscular
block induced by aminosteroidal neuromuscular blocking drugs. Compared to reversal with …

Study objective Sugammadex has been introduced for reversal of neuromuscular blockade
(NMB) induced by rocuronium (or vecuronium). Although its efficacy and safety have been …